Macías-Parra M, Rojas-Maruri M, Ridaura-Sanz C

Idioma: Español
Referencias bibliográficas: 23
Paginas: 402-410
Archivo PDF: 856.88 Kb.

RESUMEN

Se presenta el caso de un paciente con síndrome urémico hemolítico asociado con neumonía adquirida en la comunidad, complicada con empiema, que es una entidad poco frecuente pero potencialmente fatal y probablemente subdiagnosticada.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Ganzel C, Becker J, Mintz PD, Lazaruz HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: Practice management. Blood Reviews 2012;26(3):117-122.

2. Janka GE & Lehmberg K. Hemophagocytic syndromes – An update. Blood reviews 2014;28:135-142.

3. Chandrakasan S, Filipovich AH. Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis and Treatment. The Journal of Pediatrics 2013;163(5):1253- 1259.

4. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48(2):124-31.

5. Kaplan SL, Mason Jr EO, Barson WJ, Wald ER, Arditi M, Tan TQ, et al. Three-Year Multicenter Surveillance of Systemic Pneumococcal Infections in Children. Pediatrics 1998;102(3):538–45.

6. Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 2004;43(6):976–82.

7. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009;361(17):1676–87.

8. Copelovitch L, Kaplan BS. Streptococcus pneumoniaeassociated hemolytic uremic syndrome. Pediatr Nephrol 2008;23(11):1951–6.

9. Calbo E, et al. Invasive pneumococcal disease. Clinical Infectious Diseases 2005;41:1821-1822.

10. Tinsa F, et al. Pneumococcal infection and hemolytic uremic syndrome. Tunis Med 2009;87(11):790-2.

11. Oliver JW, et al. Pneumococcal Induced T Activation With Resultant Thrombotic Microangiopathy. Clinical Med Insights Pathology 2010;3:13-17.

12. D.-Byington CL, et al. Impact of the Pneumococcal. Pediatric Infection Diseases J 2006;25:250-254.

13. Canadian Paediatric Society; Health Canada. Canadian Paediatric Surveillance Program: 2002 Results. Ottawa, Ontario, Canada: Canadian Paediatric Society; 2003:27–28.

14. Brandt J, Wong C, Mihm S, Roberts J, Smith J, Brewer E, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002;110(2 Pt 1):371–6.

15. Lee C-S, Chen M-J, Chiou Y-H, Shen C-F, Wu C-Y, Chiou Y-Y. Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan. Nephrology (Carlton) 2012;17(1):48–52.

16. Copelovitch L, Kaplan BS. Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics 2010;125(1):e174–82.

17. Veesenmeyer AF, Edmonson MB. Trends in US hospital stays for Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Infect Dis J 2013;32(7):731–5.

18. Coats MT, Murphy T, Paton JC, Gray B, Briles DE. Exposure of thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase. Microb Pathog 2012;50(6):343–9.

19. Ramasethu J, Luban n. t activation. Br J Haematol 2001;112:259–263.

20. Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004;19(3):317–21.

21. Parker D, Soong G, Planet P, Brower J, Ratner AJ, Prince A. The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 2009;77(9):3722–30.

22. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, et al. Pneumococcal Necrotizing Pneumonia in Utah: Does Serotype Matter? 2013;46:1346–52.

23. Echániz- Gaviléz G, San Román Álvarez L, Sánchez- Alemán M, Carnalla- Barajas MN, Soto Nogueron. Prevalencia de Streptococcus pneumoniae serotipo 19A antes y después de la introducción de la vacuna heptavalente en México. Salud Pub de México 2014;56(3):266-271.